≡Menu

Public Health and Pandemic Relief Fraud

Home/Practice Areas/False Claims Act, Whistleblower & Qui Tam Matters/False Claims Act (Qui Tam) Representation/Public Health and Pandemic Relief Fraud

Understanding Public Health and Pandemic Relief Fraud

Public health and pandemic relief fraud occurs when individuals, businesses, or organizations misuse funds, misrepresent eligibility, or otherwise defraud government programs intended to address public health emergencies. The False Claims Act (FCA) is a key enforcement tool for holding accountable those who exploit relief funding and undermine public health initiatives.

During emergencies such as the COVID‑19 pandemic, the federal government distributed billions of dollars through relief programs, including the Paycheck Protection Program (PPP) and the Provider Relief Fund. While these funds were meant to support struggling businesses, healthcare providers, and communities, they have also been the target of significant fraud.

Examples of FCA Liability

Procurement and contract fraud occurs across a range of industries, including construction, technology, and defense. Examples include:

A construction company billing for premium building materials but supplying lower‑quality substitutes.
An IT vendor falsely certifying compliance with federal cybersecurity requirements.
A defense contractor charging for high‑grade components but delivering substandard parts.

The False Claims Act and Relief Fraud

The FCA allows whistleblowers to file qui tam lawsuits on behalf of the government to recover funds obtained through fraud. Whistleblowers may receive between 15–30% of the government’s recovery in successful cases.
Violators face treble damages—three times the government’s losses—plus significant civil penalties for each false claim submitted.

Whistleblower Protections

The FCA prohibits retaliation against employees, contractors, and agents who report relief fraud or participate in FCA investigations. Retaliation can include termination, demotion, pay cuts, harassment, or blacklisting. Remedies may include:

Reinstatement
Double back pay plus interest
Compensation for emotional distress (less common)

Reporting Public Health and Pandemic Relief Fraud

Individuals with knowledge of pandemic relief or public health fraud should:
Preserve relevant evidence, including applications, contracts, invoices, or communications.
Consult with experienced FCA counsel to evaluate the strength of potential claims.
File a qui tam complaint under seal to initiate a confidential government investigation.

Common Types of Public Health and Pandemic Relief Fraud

Misrepresenting Eligibility for Relief Programs

Applying for funds while knowingly failing to meet program eligibility requirements.

Misuse of Relief Funds

Using relief program funds for purposes unrelated to the stated purpose of the program, such as personal expenses or unauthorized business ventures.

False Reporting to Retain Funds

Submitting false information to government agencies to maintain access to relief funds or avoid repayment obligations.

Inflated Claims for Healthcare Reimbursement

Billing government programs for pandemic‑related services that were not provided, were unnecessary, or were misrepresented.

Kickback Arrangements

Offering or accepting improper payments to influence the allocation or use of relief program funds.

Frequently Asked Questions About Public Health and Pandemic Relief Fraud

What is public health and pandemic relief fraud?

Fraud involving misrepresentation, misuse, or abuse of government programs and funds intended to address public health emergencies, such as COVID‑19 relief efforts.

What programs are most often involved in pandemic relief fraud cases?

Common programs include the Paycheck Protection Program (PPP), the Provider Relief Fund, and other federal or state public health grant programs.

Who can be liable under the FCA for relief fraud?

Any person or entity that knowingly submits false claims, misrepresents eligibility, or misuses funds from public health or pandemic relief programs.

Can whistleblowers receive an award for reporting relief fraud?

Yes. Whistleblowers may receive 15–30% of the amount the government recovers in a successful case.

What protections are available to whistleblowers?

The FCA prohibits retaliation for reporting fraud or participating in a relief fraud investigation. Whistleblowers may be entitled to reinstatement, double back pay, and other damages.

How do I report suspected public health or pandemic relief fraud?

Document the misconduct, preserve evidence, and contact an attorney experienced in FCA matters before filing a complaint.

Are you ready to blow the whistle

TALK TO US

Over 1 BILLION Recovered

Our team is equipped and prepared for complicated, high-stakes cases in all areas of business and civil litigation. We continuously strive to achieve the best possible results for our clients.

View All

Novartis False Claims Act Settlement

$642 Million

Novartis False Claims Act Settlement

DST ERISA Class Action Settlement

$124.6 Million

DST ERISA Class Action Settlement

Teva False Claims Act Settlement

$54 Million

Teva False Claims Act Settlement

Norwegian Salmon Antitrust Settlement

$33 Million

Norwegian Salmon Antitrust Settlement

Virgin Airlines Wage and Hour Settlement

$31 Million

Virgin Airlines Wage and Hour Settlement

AMC Securities Settlement

$18 Million

AMC Securities Settlement

Eversource Energy ERISA Class Action Settlement

$14 Million

Eversource Energy ERISA Class Action Settlement

Universal Health Services ERISA Class Action Settlement

$12.5 Million

Universal Health Services ERISA Class Action Settlement

MedStar ERISA Class Action Settlement

$11.8 Million

MedStar ERISA Class Action Settlement

Safeway ERISA Class Action Settlement

$8.5 Million

Safeway ERISA Class Action Settlement

LinkedIn ERISA Class Action Settlement

$6.75 Million

LinkedIn ERISA Class Action Settlement

IQVIA Inc. ERISA Class Action Settlement

$3.5 Million

IQVIA Inc. ERISA Class Action Settlement

Coca-Cola ERISA Class Action Settlement

$3.5 Million

Coca-Cola ERISA Class Action Settlement

Beth Israel Medical ERISA Class Action Settlement

$2.9 Million

Beth Israel Medical ERISA Class Action Settlement

Rush University Medical ERISA Class Action Settlement

$2.9 Million

Rush University Medical ERISA Class Action Settlement

L Brands ERISA Class Action Settlement

$2.75 Million

L Brands ERISA Class Action Settlement

Omnicom ERISA Class Action Settlement

$2.45 Million

Omnicom ERISA Class Action Settlement

Find a Lawyer

Words From Our Clients

Client

James and Chris at Miller Shah LLP have been fantastic. Professional to a tee, we cannot recommend these guys enough. If you are after an attorney, then look no further. Definitely worthy of 5 stars.

Client

Anonymous

I have known Eric for many years. He is an excellent lawyer.

Brian G.

Amazing law firm, nationally recognized

Michael M.

Attentive and caring law firm.

More Testimonials

Contact
Miller Shah LLP

While this website provides general information, it does not constitute legal advice. The best way to get guidance on your specific legal issue is to contact a lawyer. To schedule a meeting with an attorney, please call 866-540-5505 or complete the intake form to email us. To inquire about employment opportunities with Miller Shah LLP, please see our Opportunities page.

Offices Throughout
the United States & Italy

Get Fort Lauderdale Directions

IT Milan

Fax number

866-540-5505

Telephone

Attorney Advertising. This information is designed for general information only. The information presented should not be construed to be formal legal advice nor the formation of a lawyer/client relationship. Past results and testimonials are not a guarantee, warranty, or prediction of the outcome of your case, and should not be construed as such. Past results cannot guarantee future performance. Any result in a single case is not meant to create an expectation of similar results in future matters because each case involves many different factors, therefore, results will differ on a case-by-case basis. By providing contact information, users acknowledge and give explicit consent to be contacted via the methods of communication provided, including SMS. Message and data rates may apply. Message frequency may vary. Reply STOP to opt out.